Skip to main content
Vendor Drug Program
Menu
Keyword search
Home
About
About the Program
Manuals
Contact Us
News
Policy
Providers
Providers
Pharmacy Search
Prescriber Search
340B Providers
Formulary
Formulary
Formulary Search
Clinician-Administered Drugs
Clinical Prior Authorizations for Managed Care
Clinical Prior Authorizations for Traditional Medicaid
Hepatitis C
Preferred Drugs
Prior Authorization
Respiratory Syncytial Virus Treatment
Specialty Drugs
Resources
Resources
Managed Care
MCO Search
Drug Utilization Review Board
Manufacturers
Downloads
Reports
Breadcrumb
Home
About
News
News Archive
News Archive
Learn more about HHSC’s collaboration with AbbVie to combat
Hepatitis C in Medicaid
.
Filter news by type
- Any -
CAD
Drug
DUR Board
Enrollment
Hepatitis C
Managed Care
Manufacturer
Mosquito benefit
PDL
Prior Authorization
Program
RSV
SDL
Vaccine
May 19, 2023
HHSC to Implement Pulmonary Hypertension Agents Clinical Prior Authorization on July 27, 2023
May 19, 2023
HHSC to Implement Sotyktu Criteria in Cytokine and CAM Antagonists Clinical Prior Authorization on July 27, 2023
May 19, 2023
HHSC to Revise Qulipta Criteria for Clinical Prior Authorization on June 27, 2023
May 17, 2023
HHSC to Implement Clinical Prior Authorization for Antimigraine Agents-Ergot Derivatives on June 6, 2023
May 17, 2023
HHSC to Implement Clinical Prior Authorization for Gattex on June 6, 2023
May 17, 2023
Change in Preferred Drug List Status for the Smoking Cessation Drug Class Effective May 16, 2023
May 10, 2023
Summary of April 2023 Drug Utilization Review Board Meeting Now Available
May 9, 2023
HHSC to Revise Opiate/Benzodiazepine/Muscle Relaxant Combinations Prior Authorization
May 5, 2023
Pharmacy Email Addresses Must Be Current in PEMS
May 5, 2023
Update to "HHSC To Implement Clinical Prior Authorizations For Fee-For-Service"
Pagination
Current page
1
Page
2
Page
3
…
Next page
Next ›
Last page
Last »
